Desferal (Novartis Pharmaceuticals Corporation)
Welcome to the PulseAid listing for the Desferal drug offered from Novartis Pharmaceuticals Corporation. This Iron Chelating Activity [MoA],Iron Chelator [EPC] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
| LABELER NAME / MANUFACTURER: | Novartis Pharmaceuticals Corporation |
| NON-PROPRIETARY NAME: | deferoxamine mesylate |
| SUBSTANCE NAME: | DEFEROXAMINE MESYLATE |
| TYPE: | HUMAN PRESCRIPTION DRUG |
| PHARMA CLASS: | Iron Chelating Activity [MoA],Iron Chelator [EPC] |
| ROUTE: | INTRAMUSCULAR; INTRAVENOUS; SUBCUTANEOUS |
| DOSAGE FORM: | INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION |
| MARKETING CATEGORY NAME: | NDA |
| START MARKETING DATE: | 1968-04-02 |
| END MARKETING DATE: | 0000-00-00 |
Desferal HUMAN PRESCRIPTION DRUG Details:
| Item Description | Desferal from Novartis Pharmaceuticals Corporation |
| LABELER NAME: | Novartis Pharmaceuticals Corporation |
| DEA SCHEDULE: |
|
| ACTIVE STRENGTH: | 500(mg/1) |
| START MARKETING DATE: | 1968-04-02 |
| END MARKETING DATE: | 0000-00-00 |
| PRODUCT ID: | 0078-0467_88530c90-9af3-42ba-8029-2f248a1c77ab |
| PRODUCT NDC: | 0078-0467 |
| APPLICATION NUMBER: | NDA016267 |
Other DEFEROXAMINE MESYLATE Pharmaceutical Manufacturers / Labelers:
